Aquestive Therapeutics, Inc. Quarterly Current Ratio in % from Q1 2019 to Q2 2024

Taxonomy & unit
ratio: %
Description
The current ratio is a liquidity ratio that measures a company's ability to cover its short-term obligations with its current assets.
Summary
Aquestive Therapeutics, Inc. quarterly Current Ratio history and growth rate from Q1 2019 to Q2 2024.
  • Aquestive Therapeutics, Inc. Current Ratio for the quarter ending June 30, 2024 was 405 %, a 289% increase year-over-year.
Current Ratio, Quarterly (%)
Current Ratio, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q2 2024 405 +301 +289% Jun 30, 2024
Q1 2024 239 +126 +111% Mar 31, 2024
Q4 2023 137 +11.2 +8.87% Dec 31, 2023
Q3 2023 116 -36.3 -23.8% Sep 30, 2023
Q2 2023 104 -78 -42.8% Jun 30, 2023
Q1 2023 113 -89.7 -44.2% Mar 31, 2023
Q4 2022 126 -87.8 -41% Dec 31, 2022
Q3 2022 153 -60.7 -28.4% Sep 30, 2022
Q2 2022 182 -26 -12.5% Jun 30, 2022
Q1 2022 203 -18.5 -8.37% Mar 31, 2022
Q4 2021 214 -31.6 -12.8% Dec 31, 2021
Q3 2021 213 -77.1 -26.5% Sep 30, 2021
Q2 2021 208 -84.4 -28.9% Jun 30, 2021
Q1 2021 221 -28.7 -11.5% Mar 31, 2021
Q4 2020 246 +28.9 +13.3% Dec 31, 2020
Q3 2020 290 +97.1 +50.2% Sep 30, 2020
Q2 2020 292 +65.3 +28.8% Jun 30, 2020
Q1 2020 250 +32 +14.7% Mar 31, 2020
Q4 2019 217 Dec 31, 2019
Q3 2019 193 Sep 30, 2019
Q2 2019 227 Jun 30, 2019
Q1 2019 218 Mar 31, 2019
* An asterisk sign (*) next to the value indicates that the value is likely invalid.